Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. | 430,500 | reported | 14 May 2019 | tx 5+1,252,334 |
| Akebia Therapeutics, Inc. | 161,729 | reported | 10 Jun 2025 | tx 20+463,132 |
| Versartis, Inc. | 97,063 | reported | 23 Sept 2022 | tx 4+149,886 |
| EyePoint, Inc. | 40,000 | reported | 25 Jun 2019 | tx 21+1,285,001−119,167 |
| BG Medicine, Inc. | 35,000 | reported | 22 Feb 2012 | tx 2+110,598 |
| ACORDA THERAPEUTICS INC | 20,000 | reported | 11 May 2016 | tx 14+295,677−12,594 |
| Fortress Biotech, Inc. | 15,000 | reported | 07 Feb 2013 | tx 2+30,000 |
| KERYX BIOPHARMACEUTICALS INC | 0 | reported | 12 Dec 2018 | tx 8+120,000−170,000 |
| MATHSTAR INC | 0 | reported | 19 Jul 2017 | tx 27+83,594−36,941 |
| INDEVUS PHARMACEUTICALS INC | 0 | reported | 24 Feb 2009 | tx 29+2,508,661−2,671,421 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 35,700 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 53,600 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 23 Sept 2022 | GRANT_AWARD | Versartis, Inc. | 97,063 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Akebia Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 10 Sept 2021 | GRANT_AWARD | Versartis, Inc. | 22,812 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD | |
| 02 Jun 2021 | GRANT_AWARD | Akebia Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 15 Sept 2020 | GRANT_AWARD | Versartis, Inc. | 14,987 | 0.00 USD | deriv |
| 15 Sept 2020 | GRANT_AWARD | Versartis, Inc. | 15,024 | 0.00 USD | deriv |
| 05 Jun 2020 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD | |
| 05 Jun 2020 | GRANT_AWARD | Akebia Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 25 Jun 2019 | GRANT_AWARD | EyePoint, Inc. | 40,000 | 0.00 USD | deriv |
| 21 Jun 2019 | EXERCISE | EyePoint, Inc. | 6,667 | 0.00 USD | |
| 21 Jun 2019 | EXERCISE | EyePoint, Inc. | 6,667 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD | |
| 06 Jun 2019 | GRANT_AWARD | Akebia Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 14 May 2019 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 430,500 | 0.00 USD | deriv |
| 14 May 2019 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 169,500 | 0.00 USD | deriv |
| 15 Feb 2019 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 215,328 | 0.00 USD | deriv |
| 12 Dec 2018 | GRANT_AWARD | Akebia Therapeutics, Inc. | 11,229 | — |
1 purchase reported after at least 12 months of silence — most recent on 10 Sept 2014.